Read More Pharma Industry News Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment… bySrinathApril 3, 2021
